Yoshiyuki Hashimoto
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology top 5%
- Oncology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Masakuni DegawaTakashi MasukoTakashi NishimuraHideki YagiTakashi SügimuraMinako NagaoYuko SeinoTakie Yahagi
- Topics
- Monoclonal and Polyclonal Antibodies Research (27 papers)Pharmacogenetics and Drug Metabolism (20 papers)Glycosylation and Glycoproteins Research (16 papers)
- Partner nations
- JapanUnited StatesIndia
In The Last Decade
Yoshiyuki Hashimoto
119 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 124
- Molecular Biology 1.0k
- Cancer Research 507
- Immunology 480
- Oncology 465
- Radiology, Nuclear Medicine and Imaging 329
Countries citing papers authored by Yoshiyuki Hashimoto
This map shows the geographic impact of Yoshiyuki Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyuki Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyuki Hashimoto more than expected).
Fields of papers citing papers by Yoshiyuki Hashimoto
This network shows the impact of papers produced by Yoshiyuki Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyuki Hashimoto. The network helps show where Yoshiyuki Hashimoto may publish in the future.
Co-authorship network of co-authors of Yoshiyuki Hashimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiyuki Hashimoto. A scholar is included among the top collaborators of Yoshiyuki Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiyuki Hashimoto. Yoshiyuki Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | 8 | |
| 3 | 14 | |
| 4 | 60 | |
| 5 | 90 | |
| 6 | 34 | |
| 7 | 25 | |
| 8 | 21 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 26 | |
| 12 | 1 | |
| 13 | 9 | |
| 14 | 4 | |
| 15 | 5 | |
| 16 | 7 | |
| 17 | 69 | |
| 18 | 11 | |
| 19 | 11 | |
| 20 | Species difference between rats and mice in activities of enzymes activating aromatic amines: effect of dietary 3-methoxy-4-aminoazobenzene. | 17 |
About Yoshiyuki Hashimoto
Yoshiyuki Hashimoto is a scholar working on Pharmacology, Biochemistry and Immunology, having authored 119 papers that have together received 2.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (27 papers), Pharmacogenetics and Drug Metabolism (20 papers) and Glycosylation and Glycoproteins Research (16 papers). The work is most often cited by research in Cancer Research (507 citations), Biochemistry (201 citations) and Pharmacology (240 citations). Yoshiyuki Hashimoto has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Masakuni Degawa, Takashi Masuko, Takashi Nishimura, Hideki Yagi, Takashi Sügimura, Minako Nagao, Yuko Seino, Takie Yahagi, Taijiro Matsushima and Toshiyuki Yamada. Their work appears in journals such as Nature, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.